Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lotriga approved in Japan for the treatment of hyperlipidemia

Oct. 1, 2012

Stem cell gene therapy shows promise in mucopolysaccharidosis IIIA model

Oct. 1, 2012

Roche presents new antidiabetic compounds

Oct. 1, 2012

Novel AMPK activators disclosed in GSK patent

Oct. 1, 2012

BioMarin to start phase III program for PEG-PAL in 2013

Sep. 28, 2012

Sanofi discloses several new agents for diabetes

Sep. 28, 2012

EE-TP shows promise for the treatment of MNGIE

Sep. 28, 2012

Minicircle plasmid DNA vector successfully treats liver disease in mice

Sep. 27, 2012

Novartis obtains positive CHMP opinions for Galvus and Eucreas

Sep. 26, 2012

Chinese group synthesizes new SGLT2 inhibitors

Sep. 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...